THE PENNANT GROUP, INC. Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest
THE PENNANT GROUP, INC. (PNTG) had Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest of $404.44 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest
us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest · last filed 2026-08-05
- 2026-06-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $404.44M.
- 2026-03-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $389.44M.
- 2025-12-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $374.25M.
- 2025-09-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $343.04M.
| Period end | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest |
|---|---|
| 2026-06-30 | $404.44M 10-Q · filed 2026-08-05 |
| 2026-03-31 | $389.44M 10-Q · filed 2026-08-05 |
| 2025-12-31 | $374.25M 10-Q · filed 2026-08-05 |
| 2025-09-30 | $343.04M 10-Q · filed 2025-11-05 |
| 2025-06-30 | $333.63M 10-Q · filed 2026-08-05 |
| 2025-03-31 | $323.03M 10-Q · filed 2026-08-05 |
| 2024-12-31 | $311.96M 10-Q · filed 2026-08-05 |
| 2024-09-30 | $187.29M 10-Q · filed 2025-11-05 |
| 2024-06-30 | $172.99M 10-Q · filed 2025-11-05 |
| 2024-03-31 | $164.23M 10-Q · filed 2025-11-05 |
| 2023-12-31 | $145.51M 10-K · filed 2026-02-26 |
| 2023-09-30 | $139.52M 10-Q · filed 2024-11-06 |
| 2023-06-30 | $133.70M 10-Q · filed 2024-11-06 |
| 2023-03-31 | $129.22M 10-Q · filed 2024-11-06 |
| 2022-12-31 | $125.66M 10-K · filed 2026-02-26 |
| 2022-09-30 | $120.84M 10-Q · filed 2023-11-07 |
| 2022-06-30 | $117.99M 10-Q · filed 2023-11-07 |
| 2022-03-31 | $117.93M 10-Q · filed 2023-11-07 |
| 2021-12-31 | $114.24M 10-K · filed 2025-02-27 |
| 2021-09-30 | $113.85M 10-Q · filed 2022-11-07 |
| 2021-06-30 | $109.98M 10-Q · filed 2022-11-07 |
| 2021-03-31 | $104.72M 10-Q · filed 2022-11-07 |
| 2020-12-31 | $101.17M 10-K · filed 2024-02-28 |
| 2020-09-30 | $89.34M 10-Q · filed 2021-11-08 |
| 2020-06-30 | $82.50M 10-Q · filed 2021-11-08 |
| 2020-03-31 | $76.19M 10-Q · filed 2021-11-08 |
| 2019-12-31 | $71.11M 10-K · filed 2023-02-23 |
| 2019-09-30 | $84.36M 10-Q · filed 2020-11-10 |
| 2019-06-30 | $86.49M 10-Q · filed 2020-11-10 |
| 2019-03-31 | $71.52M 10-Q · filed 2020-11-10 |
| 2018-12-31 | $65.29M 10-K · filed 2022-02-28 |
| 2018-09-30 | $63.69M 10-Q · filed 2019-11-12 |
| 2018-06-30 | $62.50M 10-Q · filed 2019-11-12 |
| 2018-03-31 | $62.78M 10-Q · filed 2019-11-12 |
| 2017-12-31 | $59.92M 10-K · filed 2021-02-24 |
| 2016-12-31 | $48.36M 10-K · filed 2020-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |